- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Prostate Cancer
Total 55734 results
-
National Cancer Institute, EgyptCompletedProstate Cancer MetastaticEgypt
-
University of Alabama at BirminghamSanofi; Astellas Pharma IncWithdrawn
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
Institut Paoli-CalmettesUnknown
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
DendreonCompletedMetastatic Prostate CancerUnited States
-
Sharp HealthCareWithdrawnMetastatic Prostate CancerUnited States
-
DexTech Medical ABTerminatedProstate Cancer MetastaticSweden
-
Centre Jean PerrinCompletedMetastatic Prostate CancerFrance
-
University Hospital, RouenCompleted
-
University of FloridaWithdrawnMetastatic Prostate Cancer
-
Universität des SaarlandesRecruitingProstate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic CancerGermany
-
The Netherlands Cancer InstituteBayerCompletedBone Metastases | Prostate Cancer MetastaticNetherlands
-
Hellenic Cooperative Oncology GroupSanofiCompletedBone Metastatic Prostate CancerGreece
-
BayerCompletedNon-metastatic Prostate Cancer | Non-metastatic Castration-resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)TerminatedProstate Neoplasms | Metastatic Castration Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)Enrolling by invitationProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Prostate Neoplasms | Prostatic CancerUnited States
-
Celsee DiagnosticsWithdrawnMetastatic Prostate Cancer, CTC
-
AstraZenecaCompletedNon-metastatic Prostate CancerUnited States, Canada
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
AstraZenecaScandinavian Prostate Cancer GroupCompletedNon-Metastatic Prostate CancerSweden, Finland, Norway, Denmark
-
AstraZenecaCompletedNon-Metastatic Prostate CancerFinland
-
Shanghai Humantech Biotechnology Co. LtdShanghai Changhai Hospital,The First Affiliated Hospital of Naval Medical...RecruitingMetastatic Castration-resistant Prostate CancerChina
-
UNICANCERBayerRecruitingProstate Cancer MetastaticSpain, France, Ireland, Belgium
-
FutureChemCompletedMetastatic Castration-resistant Prostate CancerKorea, Republic of
-
Azienda Ospedaliero-Universitaria CareggiCompletedMetastatic Prostate Cancer | Elderly PatientsItaly
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
Hinova Pharmaceuticals Inc.CompletedMetastatic Castration Resistant Prostate CancerChina
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Cancer | Metastatic Castrate Resistant Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Medivation, Inc.Approved for marketingMetastatic Castration-Resistant Prostate Cancer
-
Duke UniversityUnited States Department of DefenseCompletedMetastatic Hormone Refractory Prostate CancerUnited States
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
University Hospital, GhentRecruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | OligometastasisBelgium
-
National Cancer Institute (NCI)RecruitingProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Cancer Of Prostate | ProstateUnited States
-
Progenics Pharmaceuticals, Inc.CompletedStudy of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (CONDOR)Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States, Canada
-
AstraZenecaCompletedMetastatic Castration-resistant Prostates CancerIndia, Peru, Saudi Arabia, Egypt, Colombia, Korea, Republic of, Turkey, United Arab Emirates
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
Peking Union Medical College HospitalRecruitingMetastatic Castration-resistant Prostate CancerChina
-
Lava TherapeuticsRecruitingMetastatic Castration Resistant Prostate CancerUnited States
-
Sun Yat-sen UniversityRecruitingMetastatic Castration-resistant Prostate CancerChina
-
Tulane UniversityBlue Earth DiagnosticsCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
National Cancer Institute, NaplesActive, not recruitingMetastatic Castration-resistent Prostate CancerItaly
-
Opna-IO LLCTerminatedMetastatic Castration-resistant Prostate CancerUnited States, United Kingdom
-
Duke UniversityExelixisTerminatedProstate Cancer | Prostate Cancer Adenocarcinoma | Non-MetastaticUnited States
-
Zenith EpigeneticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
EndocyteTerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.UnknownMetastatic Castration Resistant Prostate Cancer
-
Pellficure Pharmaceuticals, IncTerminatedMetastatic Castration-Resistant Prostate CancerUnited States